🇺🇸 FDA
Pipeline program

Live-Attenuated influenza Vaccine(LAIV)

F20160728

Phase 3 mab completed

Quick answer

Live-Attenuated influenza Vaccine(LAIV) for Influenza is a Phase 3 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Influenza
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials